Enliven Therapeutics, Inc.ELVNNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9 | -25↓165.7% | -39↓56.7% | -84↓115.3% | -105↓25.2% |
| Net Income | -19 | -25↓30.4% | -38↓52.2% | -72↓90.1% | -89↓24.4% |
| EBITDA | -9 | -25↓165.8% | -39↓56.5% | -83↓115.8% | -104↓25.2% |
| EPS Diluted | -4.31 | -3.17↑26.5% | -6.03↓90.2% | -2.01↑66.7% | -1.89↑6.0% |